These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 37978443)
1. Evaluation of vital genes correlated with CD8 + T cell infiltration as prognostic biomarkers in stomach adenocarcinoma. Pan D; Chen H; Xu J; Lin X; Li L BMC Gastroenterol; 2023 Nov; 23(1):399. PubMed ID: 37978443 [TBL] [Abstract][Full Text] [Related]
2. Identification of Key Genes Related to CD8+ T-Cell Infiltration as Prognostic Biomarkers for Lung Adenocarcinoma. Du M; Liang Y; Liu Z; Li X; Liang M; Zhou B; Gao Y Front Oncol; 2021; 11():693353. PubMed ID: 34650911 [TBL] [Abstract][Full Text] [Related]
3. Data mining combines bioinformatics discover immunoinfiltration-related gene SERPINE1 as a biomarker for diagnosis and prognosis of stomach adenocarcinoma. Zhai Y; Liu X; Huang Z; Zhang J; Stalin A; Tan Y; Zhang F; Chen M; Shi R; Huang J; Wu C; Wu Z; Lu S; You L; Wu J Sci Rep; 2023 Jan; 13(1):1373. PubMed ID: 36697459 [TBL] [Abstract][Full Text] [Related]
4. Identification of prognosis-related genes in the tumor microenvironment of stomach adenocarcinoma by TCGA and GEO datasets. Ren N; Liang B; Li Y Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33015704 [TBL] [Abstract][Full Text] [Related]
5. Development of an immunogenic cell death prognostic signature for predicting clinical outcome and immune infiltration characterization in stomach adenocarcinoma. Liu Y; Zhang L; Lei X; Yin X; Liu S Aging (Albany NY); 2023 Oct; 15(20):11389-11411. PubMed ID: 37862109 [TBL] [Abstract][Full Text] [Related]
6. Construction of mRNA prognosis signature associated with differentially expressed genes in early stage of stomach adenocarcinomas based on TCGA and GEO datasets. Jiang F; Lin H; Yan H; Sun X; Yang J; Dong M Eur J Med Res; 2022 Oct; 27(1):205. PubMed ID: 36253873 [TBL] [Abstract][Full Text] [Related]
7. Construction of a Prognostic Evaluation Model for Stomach Adenocarcinoma on the Basis of Immune-Related lncRNAs. Xu C; Chen Z; Pan X; Liu M; Cheng G; Li J; Mei Y Appl Biochem Biotechnol; 2022 Dec; 194(12):6255-6269. PubMed ID: 35904674 [TBL] [Abstract][Full Text] [Related]
8. Construction of a prognostic risk model for Stomach adenocarcinoma based on endoplasmic reticulum stress genes. Li X; Lei Y Wien Klin Wochenschr; 2024 Jun; 136(11-12):319-330. PubMed ID: 37993598 [TBL] [Abstract][Full Text] [Related]
9. Angiogenesis-related lncRNAs predict the prognosis signature of stomach adenocarcinoma. Han C; Zhang C; Wang H; Li K; Zhao L BMC Cancer; 2021 Dec; 21(1):1312. PubMed ID: 34876056 [TBL] [Abstract][Full Text] [Related]
10. Construction and Validation of a Novel Pyroptosis-Related Four-lncRNA Prognostic Signature Related to Gastric Cancer and Immune Infiltration. Wang Z; Cao L; Zhou S; Lyu J; Gao Y; Yang R Front Immunol; 2022; 13():854785. PubMed ID: 35392086 [TBL] [Abstract][Full Text] [Related]
11. Classification of stomach adenocarcinoma based on fatty acid metabolism-related genes frofiling. Liu C; Tao Y; Lin H; Lou X; Wu S; Chen L Front Mol Biosci; 2022; 9():962435. PubMed ID: 36090054 [No Abstract] [Full Text] [Related]
12. WGCNA identification of TLR7 as a novel diagnostic biomarker, progression and prognostic indicator, and immunotherapeutic target for stomach adenocarcinoma. Yuan Q; Zhou Q; Ren J; Wang G; Yin C; Shang D; Xia S Cancer Med; 2021 Jun; 10(12):4004-4016. PubMed ID: 33982398 [TBL] [Abstract][Full Text] [Related]
13. A novel prognostic index of stomach adenocarcinoma based on immunogenomic landscape analysis and immunotherapy options. Xue W; Dong B; Wang Y; Xie Y; Li P; Gong Z; Niu Z Exp Mol Pathol; 2022 Oct; 128():104832. PubMed ID: 36122795 [TBL] [Abstract][Full Text] [Related]
14. Constructing a novel gene signature derived from oxidative stress specific subtypes for predicting survival in stomach adenocarcinoma. Zhou R; Peng N; Li W Front Immunol; 2022; 13():964919. PubMed ID: 36059494 [TBL] [Abstract][Full Text] [Related]
15. Construction of a disulfidptosis-related glycolysis gene risk model to predict the prognosis and immune infiltration analysis of gastric adenocarcinoma. Liao Z; Xie Z Clin Transl Oncol; 2024 Sep; 26(9):2309-2322. PubMed ID: 38587603 [TBL] [Abstract][Full Text] [Related]
16. Cuproptosis-Related lncRNA Gene Signature Establishes a Prognostic Model of Gastric Adenocarcinoma and Evaluate the Effect of Antineoplastic Drugs. Tu H; Zhang Q; Xue L; Bao J Genes (Basel); 2022 Nov; 13(12):. PubMed ID: 36553481 [TBL] [Abstract][Full Text] [Related]
17. Development and validation of an immune-related gene prognostic model for stomach adenocarcinoma. Wu M; Xia Y; Wang Y; Fan F; Li X; Song J; Ding J Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33112406 [TBL] [Abstract][Full Text] [Related]
18. Potential Prognostic Value and Mechanism of Stromal-Immune Signature in Tumor Microenvironment for Stomach Adenocarcinoma. Zhu X; Xie X; Zhao Q; Zhang L; Li C; Zhao D Biomed Res Int; 2020; 2020():4673153. PubMed ID: 32685487 [TBL] [Abstract][Full Text] [Related]
19. Immunobiological signatures and the emerging role of SPP1 in predicting tumor heterogeneity, malignancy, and clinical outcomes in stomach adenocarcinoma. Wu Y; Ren L; Tang Y; Zhu Z; Liu S; Jiang Y; Zhang S; Zhuang X; Chen Y Aging (Albany NY); 2023 Oct; 15(20):11588-11610. PubMed ID: 37889539 [TBL] [Abstract][Full Text] [Related]
20. Identification of three immune subtypes characterized by distinct tumor immune microenvironment and therapeutic response in stomach adenocarcinoma. Zhu Y; Zhao Y; Cao Z; Chen Z; Pan W Gene; 2022 Apr; 818():146177. PubMed ID: 35065254 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]